DB11727InvestigationalProtein Based Therapies
Endostar is under investigation for the treatment of Nasopharyngeal Carcinoma. Endostar has been investigated for the treatment of Non-small Cell Lung Cancer.
- Also known as
- Endostatin, N-terminal-MGGSHHHHH · N-TERMINAL-MGGSHHHHH-ENDOSTATIN · N-TERMINAL-MGGSHHHHH-ENDOSTATIN (HUMAN RECOMBINANT) · Recombinant human endostatin protein
Resolves to
Compound
What you can answer from here — as of April 02, 2025
Which companies are running trials of Endostar, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account